Koninklijke Philips NV ADR (PHG) revenue breakdown
By segment, Diagnosis & Treatment is the largest at 48% of fiscal 2025 revenue, growing 3% a year over 9 years.
By region, United States is the largest at 40% of fiscal 2025 revenue; Netherlands grew fastest, 8% a year over 4 years.
Revenue by segment
Fiscal years, as Koninklijke Philips NV ADR reports them in its 10-K filings; fiscal 2025 total $17.8B.
| Segments | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Diagnosis & Treatment | $6.7B | $7.4B | $7.7B | $8.5B | $8.2B | $7.8B | $8.3B | $8.8B | $8.8B | $8.5B | 48% |
| Connected Care | — | $4.3B | $4.3B | $4.7B | $5.5B | $5.4B | $5.3B | $5.1B | $5.1B | $5.1B | 28% |
| Personal Health | $7.1B | $5.7B | $5.5B | $3.5B | $3.2B | $3.4B | $3.6B | $3.6B | $3.5B | $3.7B | 21% |
| Other | $479M | $400M | $530M | $472M | $396M | $530M | $630M | $604M | $611M | $554M | 3% |
| Connected Care & Health Informatics | $3.2B | — | — | — | — | — | — | — | — | — | — |
Revenue by region
Fiscal years, as Koninklijke Philips NV ADR reports them in its 10-K filings; fiscal 2025 total $17.8B.
| Regions | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | — | — | — | — | — | $6.4B | $7.2B | $7.2B | $7.2B | $7.1B | 40% |
| Other countries | — | — | — | — | — | $4.2B | $5.7B | $5.7B | $5.6B | $5.4B | 30% |
| Netherlands | — | — | — | — | — | $1.9B | $2.0B | $2.4B | $2.5B | $2.5B | 14% |
| China | — | — | — | — | — | $1.4B | $1.2B | $1.4B | $1.2B | $1.2B | 7% |
| Japan | — | — | — | — | — | $1.1B | $1.0B | $941M | $886M | $883M | 5% |
| Germany | — | — | — | — | — | $970M | $642M | $573M | $653M | $652M | 4% |
| North America | — | — | — | $6.8B | $6.8B | — | — | — | — | — | — |
| North America | $6.3B | — | — | — | — | — | — | — | — | — | — |
| Other countries | — | — | $6.1B | — | — | — | — | — | — | — | — |
| UNITED STATES | — | $6.1B | — | — | — | — | — | — | — | — | — |
| United States of America | — | — | $6.0B | — | — | — | — | — | — | — | — |
| Other countries | — | $5.9B | — | — | — | — | — | — | — | — | — |
| Growth Geographies | — | — | — | $5.1B | $5.0B | — | — | — | — | — | — |
| Western Europe | $3.8B | — | — | — | — | — | — | — | — | — | — |
| Western Europe | — | — | — | $3.3B | $3.7B | — | — | — | — | — | — |
| China | $2.2B | $2.3B | $2.4B | — | — | — | — | — | — | — | — |
| Other Mature Geographies | $1.8B | — | — | — | — | — | — | — | — | — | — |
| Other Mature Geographies | — | — | — | $1.5B | $1.4B | — | — | — | — | — | — |
| Japan | $1.1B | $1.1B | $1.0B | — | — | — | — | — | — | — | — |
| Germany | $965M | $1.0B | $1.0B | — | — | — | — | — | — | — | — |
| France | $513M | $530M | $519M | — | — | — | — | — | — | — | — |
| Netherlands | $393M | $414M | $510M | — | — | — | — | — | — | — | — |
| India | — | — | $498M | — | — | — | — | — | — | — | — |
| France | — | — | — | — | — | $446M | — | — | — | — | — |
| India | — | — | — | — | — | $431M | — | — | — | — | — |
| United Kingdom of Great Britain and Northern Ireland | — | — | — | — | — | $426M | — | — | — | — | — |
| INDIA | — | $425M | — | — | — | — | — | — | — | — | — |
| India | $399M | — | — | — | — | — | — | — | — | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for PHG.
Open PHG in InvestinglyQuestions
Where does Koninklijke Philips NV ADR make its money?
In fiscal 2025, by segment: Diagnosis & Treatment $8.5B, Connected Care $5.1B, Personal Health $3.7B, Other $554M.
From Koninklijke Philips NV ADR's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.